A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States ‐ 2007 to 2016-Reference-Cited by-同舟云学术

A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States ‐ 2007 to 2016

Published:2020-07-21 Issue:9 Volume:29 Page:1054-1063
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Perry Lucy T.¹^ORCID,Bhasale Alice¹^ORCID,Fabbri Alice¹²^ORCID,Lexchin Joel³^ORCID,Puil Lorri⁴^ORCID,Joarder Maisah¹^ORCID,Mintzes Barbara¹^ORCID

Affiliation:

1. School of Pharmacy, Faculty of Medicine and Health, and Charles Perkins Centre University of Sydney Sydney New South Wales Australia

2. Centre for Evidence Based Medicine Odense Odense University Hospital and University of Southern Denmark Odense Denmark

3. School of Health Policy & Management, Faculty of Health York University Toronto Ontario Canada

4. Department of Anaesthesiology, Pharmacology & Therapeutics, Faculty of Medicine University of British Columbia Vancouver British Columbia Canada

Funder

Canadian Institutes of Health Research

National Health and Medical Research Council

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5072

Reference23 articles.

1. Comparative Analysis of Medicines Safety Advisories Released by Australia, Canada, the United States, and the United Kingdom

2. Inconsistencies among European Union Pharmaceutical Regulator Safety Communications: A Cross-Country Comparison

3. A call for international harmonization in therapeutic risk management

4. Comparative, cross-sectional study of the format, content and timing of medication safety letters issued in Canada, the USA and the UK

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An exploratory study of knowledge, attitudes, practice and barriers towards adverse drug reaction reporting among healthcare professionals in Malta;International Journal of Risk & Safety in Medicine;2024-08-29

2. Information Sources for Drug Safety and Communicating Risks in Practice;Principles and Practice of Pharmacovigilance and Drug Safety;2024

3. Sustained Decline of Direct General Practitioner Reporting of Adverse Drug Reactions in Australia and Paucity in Details of Australian Reports in Safety Advisories;Drug Safety;2023-06-02

4. Characteristics of drug safety alerts issued by the Spanish Medicines Agency;Frontiers in Pharmacology;2023-01-30

5. How do safety warnings on medicines affect prescribing?;Expert Opinion on Drug Safety;2022-10-03